Blissy Silk Pillowcases
Company hits snooze on promised marketing changes.
Faulkner et al. v. Acella Pharmaceuticals, LLC
22-cv-92, N.D. Ga.
(May 2022)
NP Thyroid
Falsely marketing that medications contain a specific amount of the active ingredient when certain batches were recalled for containing too much or too little of the active ingredient
Falsely marketing medications as safe when certain batches were recalled because the amount of the active ingredient could cause serious adverse health consequences or death
Falsely marketing that medications are “[m]ade with the highest quality standards” and comply with applicable USP standards
Settled
(Final approval granted)
Company hits snooze on promised marketing changes.
Some things come with age. And some don’t.
Matt Gephardt, KSL.com
Is this drink’s packaging whispering sweet nothings?
Subscription streaming service isn’t the only way to catch the game.